Exhibit 1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned does hereby consent and agree to the joint filing on behalf of each of them of a Statement on Schedule 13G and all amendments thereto with respect to the Common Stock, par value $0.001 per share, of Navidea Biopharmaceuticals, Inc. beneficially owned by each of them, and to the inclusion of this Joint Filing Agreement as an exhibit thereto.
|
Dated: July 27, 2012
|
| |
|
PLATINUM-MONTAUR LIFE SCIENCES, LLC
|
| |
|
By: /s/ OLIVER JIMENEZ
|
|
Name: Oliver Jimenez
|
|
Title: Chief Compliance Officer
|
| |
|
PLATINUM PARTNERS VALUE ARBITRAGE FUND L.P.
|
| |
|
By: /s/ OLIVER JIMENEZ
|
|
Name: Oliver Jimenez
|
|
Title: Chief Compliance Officer
|